文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

核心技术专利：CN118964589B侵权必究

Holzbecher M, Ellenberger H A, Marsh J M, Boudreau S

Clin Biochem. 1979 Apr;12(2):66-7. doi: 10.1016/s0009-9120(79)80010-7.

A procedure for the routine assay of Naproxen in serum by ultraviolet spectrophotometry is presented. The absorption coefficient (A1 1% cm) of Naproxen in methanol at 261 nm was found to be 216. 2. The Naproxen procedure appears to be relatively free from interferences of commonly coadministered medications. Salicylate interference is eliminated by a modified procedure. 3. Concentrations of Naproxen in a limited number (40) of clinical samples ranged from non-detected to 12.5 mg/dl. The therapeutic concentration appears to be 4 to 6 mg/dl (174-260 mumol/L).

介绍了一种用紫外分光光度法常规测定血清中萘普生的方法。发现萘普生在甲醇中于261nm处的吸收系数（A1 1% cm）为216。2. 萘普生测定方法似乎相对不受常用合并用药的干扰。通过改进的方法可消除水杨酸盐的干扰。3. 有限数量（40个）临床样本中萘普生的浓度范围为未检测到至12.5mg/dl。治疗浓度似乎为4至6mg/dl（174 - 260μmol/L）。

Holzbecher M, Ellenberger H A, Marsh J M, Boudreau S

Clin Biochem. 1979 Apr;12(2):66-7. doi: 10.1016/s0009-9120(79)80010-7.

A procedure for the routine assay of Naproxen in serum by ultraviolet spectrophotometry is presented. The absorption coefficient (A1 1% cm) of Naproxen in methanol at 261 nm was found to be 216. 2. The Naproxen procedure appears to be relatively free from interferences of commonly coadministered medications. Salicylate interference is eliminated by a modified procedure. 3. Concentrations of Naproxen in a limited number (40) of clinical samples ranged from non-detected to 12.5 mg/dl. The therapeutic concentration appears to be 4 to 6 mg/dl (174-260 mumol/L).

介绍了一种用紫外分光光度法常规测定血清中萘普生的方法。发现萘普生在甲醇中于261nm处的吸收系数（A1 1% cm）为216。2. 萘普生测定方法似乎相对不受常用合并用药的干扰。通过改进的方法可消除水杨酸盐的干扰。3. 有限数量（40个）临床样本中萘普生的浓度范围为未检测到至12.5mg/dl。治疗浓度似乎为4至6mg/dl（174 - 260μmol/L）。